KOREA WHO

Chun Jong-yoon is the CEO of Seegene.

He is pursuing new growth drivers to lead Seegene in the post-COVID endemic era.

He seeks to share Seegene’s molecular diagnostic technology and infrastructure with the world and promote open innovation in the diagnostic ecosystem.

He was born on July 6, 1957, in Gyeongsan, North Gyeongsang Province, the third child among three sons and two daughters.

He graduated from Konkuk University with a degree in agriculture and earned a Ph.D. in molecular biology from the University of Tennessee.

He worked as a postdoctoral researcher at Harvard University and UC Berkeley, and served as a senior researcher at the Kumho Life Science Research Institute.

He later became a professor in the Department of Life Sciences at the Gwangju Institute of Science and Technology (GIST) and the Department of Biological Sciences at Ewha Womans University.

In 2000, while teaching at Ewha Womans University, he founded Seegene. He launched the business on the advice of his uncle, Chun Kyung-joon, former executive vice president of technology at Samsung Electronics and current chairman of Seegene.

In 2001, he resigned from his professorship to devote himself entirely to management.

By developing COVID-19 diagnostic products at the right time, he grew the company into one with revenue surpassing KRW 1 trillion (US$ 719.4 million).

#Seegene #ChunJongyoon #moleculardiagnostics #COVID19 #openinnovation #diagnostics #Koreanbiotech #healthcare #lifescience #globalexpansion